Product Information
CARAFATE 1 GM TABLET is a brand product labeled by Allergan, Inc., priced at $4.7395 per EA under NDC 58914017110. Its NADAC has been published 184 times since Dec 21, 2022.
The High Outlier badge above means this manufacturer's average price in the Sucralfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 g/1
Manufacturer
Allergan, Inc.NDC
58914017110
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUCRALFATEApproval Type
New Drug (NDA)
FDA Application
NDA018333On Market Since
10/30/1981
Pharmacological Classes
Price Statistics
The NADAC for CARAFATE 1 GM TABLET has been published 184 times since Dec 21, 2022, and over the history we have for it it has risen 10.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.7395 per EA |
|---|---|
| All-time high | $4.7678 (Feb 12, 2025) |
| All-time low | $4.3021 (Dec 21, 2022) |
| 52-week high | $4.7587 |
| 52-week low | $4.7349 |
| Median price | $4.7430 |
| Average price | $4.6750 |
| Largest weekly change | +5.0% (Jan 11, 2023) |
| Weeks tracked | 184 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARAFATE 1 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARAFATE 1 GM TABLET, manufactured by Allergan, Inc., is $4.7395 per EA (NDC 58914017110), effective Jun 24, 2026.
How has the price of CARAFATE 1 GM TABLET changed over time?
Over the history we have for it, the NADAC for CARAFATE 1 GM TABLET has risen 10.2%. It has been tracked across 184 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for CARAFATE 1 GM TABLET?
Since Dec 21, 2022, the NADAC for CARAFATE 1 GM TABLET has ranged from a low of $4.3021 (Dec 21, 2022) to a high of $4.7678 (Feb 12, 2025), with a median of $4.7430 per EA.
Are there cheaper alternatives to CARAFATE 1 GM TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, SUCRALFATE 1 GM TABLET, is $0.1830 per EA — about 96% below CARAFATE 1 GM TABLET.
Who manufactures CARAFATE 1 GM TABLET?
CARAFATE 1 GM TABLET (NDC 58914017110) is labeled by Allergan, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification